Literature DB >> 7915321

Restoration of dopamine overflow and clearance from the 6-hydroxydopamine lesioned rat striatum reinnervated by fetal mesencephalic grafts.

Y Wang1, S D Wang, S Z Lin, J C Liu.   

Abstract

The purpose of these experiments was to investigate the electrochemical indices of mesencephalic dopaminergic grafts as they function in the rat striatum. Sprague-Dawley rats were injected unilaterally with 6-hydroxydopamine into the medial forebrain bundle, and the effectiveness of these lesions was tested by measuring apomorphine-induced rotation. The unilaterally lesioned rats were later transplanted with fetal ventral mesencephalon. Only animals receiving ventral mesencephalon transplants showed significant decreases in rotation after grafting. High-speed chronoamperometric recording techniques using Nation-coated carbon fiber electrodes were used to evaluate dopamine (DA) overflow in the striatum of urethane-anesthetized rats. We found that 6-hydroxydopamine lesions resulted in a loss of KCl-induced DA overflow and clearance. Ventral mesencephalon grafts restored neurochemical indices. The zone of normalized DA clearance was considerably larger than that of normalized release. Furthermore, histochemical studies using tyrosine hydroxylase immunoreactivity confirmed graft survival and neurite outgrowth from the graft into the lesioned striatum. In conclusion, these findings suggest that the behavioral improvements by grafts of fetal mesencephalic tissue are accompanied by morphological and electrochemical evidence of reinnervation and the restoration of DA input. Measurement of DA clearance may reveal a wider area of reinnervation than that indicated by more traditional immunocytochemical methods.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7915321

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease.

Authors:  Jose A Rodríguez-Gómez; Jian-Qiang Lu; Iván Velasco; Seth Rivera; Sami S Zoghbi; Jeih-San Liow; John L Musachio; Frederick T Chin; Hiroshi Toyama; Jurgen Seidel; Michael V Green; Panayotis K Thanos; Masanori Ichise; Victor W Pike; Robert B Innis; Ron D G McKay
Journal:  Stem Cells       Date:  2006-12-14       Impact factor: 6.277

2.  Foetal nigral cell suspension grafts influence dopamine release in the non-grafted side in the 6-hydroxydopamine rat model of Parkinson's disease: in vivo voltammetric data.

Authors:  C D Earl; T Reum; J X Xie; J Sautter; A Kupsch; W H Oertel; R Morgenstern
Journal:  Exp Brain Res       Date:  1996-04       Impact factor: 1.972

3.  Enhanced survival of dopaminergic neuronal transplants in hemiparkinsonian rats by the p53 inactivator PFT-α.

Authors:  J Chou; N H Greig; D Reiner; B J Hoffer; Y Wang
Journal:  Cell Transplant       Date:  2011-02-03       Impact factor: 4.064

4.  Constructing a new nigrostriatal pathway in the Parkinsonian model with bridged neural transplantation in substantia nigra.

Authors:  F C Zhou; Y H Chiang; Y Wang
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

5.  Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease.

Authors:  Kimberly B Bjugstad; Yang D Teng; D Eugene Redmond; John D Elsworth; Robert H Roth; Shannon K Cornelius; Evan Y Snyder; John R Sladek
Journal:  Exp Neurol       Date:  2008-02-14       Impact factor: 5.330

Review 6.  Historical perspective of cell transplantation in Parkinson's disease.

Authors:  Alejandra Boronat-García; Magdalena Guerra-Crespo; René Drucker-Colín
Journal:  World J Transplant       Date:  2017-06-24

Review 7.  Enhanced survival of human-induced pluripotent stem cell transplant in parkinsonian rat brain by locally applied cyclosporine.

Authors:  Michael Sheyner; Seong-Jin Yu; Yun Wang
Journal:  Brain Circ       Date:  2019-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.